Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease

Mehmet Kanbay*, Myles Wolf, Yusuf Selcoki, Yalcin Solak, Mustafa Ikizek, Sema Uysal, Liviu Segall, Ferah Armutcu, Beyhan Eryonucu, Murat Duranay, David Goldsmith, Adrian Covic

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Background: Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). Recent data implicate disordered bone and mineral metabolism, including changes in serum levels of calcium, phosphate, parathyroid hormone (PTH), vitamin D, fibroblast growth factor-23 (FGF- 23), and fetuin A, as novel risk factors for arterial calcification. The potential role of calcitonin, another hormonal regulator of mineral and bone metabolism, has not been studied in detail. Materials and methods We investigated the link between serum calcitonin and the total burden of coronary artery disease (CAD) using the validated Gensini score, in a cross-sectional study of 88 patients with estimated GFR (eGFR) between 46 and 87 ml/ min/1.73 m2 who underwent coronary angiography. We evaluated the associations between serum calcitonin, minerals (calcium, phosphate), calcium 9 phosphate product, and other factors that regulate mineral metabolism (intact PTH, 25-OH-vitamin D, FGF-23, and fetuin A) and the severity of CAD. Results: The mean serum calcitonin was 11.5 ± 7.8 pg/ml. In univariate analysis, the Gensini CAD severity score correlated significantly with male gender, eGFR, and serum levels of 25-OH-vitamin D, iPTH, FGF-23, fetuin A, and calcitonin (R = 0.474, P = 0.001 for the latter). In multivariate analysis adjusted for calcium, phosphate, 25-OH-vitamin D, iPTH, FGF 23, fetuin A, and calcitonin, only calcitonin (b = 0.20; P = 0.03), FGF-23, fetuin A, and 25-OH-vitamin D emerged as independent predictors of Gensini score. In the second step, we adjusted for the presence of traditional risk factors, proteinuria, and GFR. After these adjustments, the FGF-23 and fetuin A remained statistically significant predictors of the Gensini score, while calcitonin did not. Conclusions Our study suggests that, in addition to other well-known components of mineral metabolism, increased calcitonin levels are associated with greater severity of CAD. However, this relation was not independent of traditional and nontraditional cardiovascular risk factors. Longitudinal studies in larger populations including patients with more advanced CKD are needed.

Original languageEnglish (US)
Pages (from-to)1169-1175
Number of pages7
JournalInternational urology and nephrology
Issue number4
StatePublished - Aug 2012


  • Bone
  • Calcitonin
  • Coronary artery disease
  • Mineral

ASJC Scopus subject areas

  • Nephrology
  • Urology


Dive into the research topics of 'Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease'. Together they form a unique fingerprint.

Cite this